Elective radiation therapy for high-risk malignant melanomas

Cancer Journal

Volumn 7, Issue 6, 2001, Pages 498-502

  Cooper, Jay S ^a,b   Chang, Won S ^a,b   Oratz, Ruth ^a,b   Shapiro, Richard L ^a,b   Roses, Daniel F ^a,b  

^a New York University School of Medicine ^*

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elective treatment; High risk; Malignant melanoma; Radiation therapy; Skin neoplasms; Treatment outcome

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CELLULITIS; CLINICAL ARTICLE; ERYTHEMA; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; MORTALITY; PATHOLOGY; RADIATION DOSE; RISK FACTOR; SKIN TUMOR; SURVIVAL RATE;

ADULT; AGED; FEMALE; HUMAN; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGE; RADIOTHERAPY DOSAGE; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0035516363     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dewey DL. The radiosensitivity of melanoma cells in culture. Br J Radiol 1971;44:816-817.
2. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 1971;31:830-833.
3. Habermalz HJ, Fischer JJ. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer 1976;38:2258-2262.
4. Hornsey S. The relationship between total dose, number of fractions and fractions size in the response of malignant melanoma in patients. Br J Radiol 1978;51:905-909.
5. Overgaard J. Radiation treatment of malignant melanoma. Int J Radiat Oncol Biol Phys 1980;6:41-44.
6. Trott KR, von Lieven H, Kummermehr J et al. The radiosensitivity of malignant melanomas part II: clinical studies, Int J Radiat Oncol Biol Phys 1981;7:15-20.
7. Rounsaville MC, Cantril ST, Fontanesi J et al. Radiotherapy in the management of cutaneous melanoma: effect of time, dose, and fractionation. Front Radiat Ther Oncol 1988;22:62-78.
8. Lobo PA, Liebner EJ, Chao JJ et al. Radiotherapy in the management of malignant melanoma, Int J Radiat Oncol Biol Phys 1981;7:21-26.
9. Kaplan EL, Meier P.P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
10. O'Brien CJ, Coates AS, Petersen-Schaefer K et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-314.
11. O'Brien CJ, Gianoutsos MP, Morgan MJ. Neck dissection for cutaneous malignant melanoma. World J Surg 1992;16:222-226.
12. Byers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch Surg 1986;121:1338-1341.
13. Lee RJ, Gibbs JF, Proulx GM et al. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2000;46:467-474.
14. Ross M, Meyer JL. Management of the regional lymph nodes in malignant melanoma: surgery, radiotherapy or observation. Front Radiat Ther Oncol 1994;28:226-234.
15. Ang KK, Byers RM, Peters LJ et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma: preliminary results. Arch Otolaryngol Head Neck Surg 1990;116:169-172.
16. Ang KK, Peters LJ, Weber RS et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994;30:795-798.
17. O'Brien CJ, Petersen-Schaefer K, Stevens GN el al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 1997;19:589-594.
18. Corry J, Smith JG, Bishop M et al. Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 1999;44:1065-1069.